NCT05578027

Brief Summary

Moxibustion plays an important role in Traditional Medicine treatments, which treats and prevents diseases by burning a herb preparation containing Moxa (Artemisia vulgaris, Mugwort) to stimulate the meridians of human body. Moxibustion is considered a safe and effective traditional therapy. Mild moxibustion is a kind of therapeutic method which characterized by wide indications, simple manipulation and comfortable feeling, is commonly used in clinical treatment. Mingmen acupoint located on the midline of the lower back, in the depression below the spinous process of the 2nd lumbar vertebra (L2). Its indications include Yang-deficiency syndrome, Cold-Stagnation syndrome, Cold Excessive syndrome,... and it is closely related to the knee area through the path of Thoroughfare Vessel (one of the Eight Extraordinary Vessels). In our study, we investigate the change in skin surface temperature at the knee area on both sides when using mild moxibustion manipulation at Mingmen acupoint with moxa stick in healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P50-P75 for not_applicable healthy-volunteers

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 10, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 13, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

9 months

First QC Date

October 10, 2022

Last Update Submit

October 18, 2023

Conditions

Keywords

MoxibustionSkin surface temperature

Outcome Measures

Primary Outcomes (2)

  • Change in skin surface temperature at the local stimulated area when using mild moxibustion manipulation at Mingmen acupoint

    During procedure

  • Change in skin surface temperature at the knee area on both sides when using mild moxibustion manipulation at Mingmen acupoint

    During procedure

Study Arms (2)

Group A: P1M2

EXPERIMENTAL

19 participants received mild moxibustion manipulation at the control acupoint (the left side Pishu acupoint) and the research acupoint (Mingmen) in the first and the second trial phase, respectively. In each trial phase, skin surface temperature at the local stimulated area and the knee area on both sides will be recorded.

Procedure: Mild moxibustion with moxa stick

Group B: M1P2

EXPERIMENTAL

19 participants received mild moxibustion manipulation at the research acupoint (Mingmen) and the control acupoint (the left side Pishu acupoint) in the first and the second trial phase, respectively. In each trial phase, skin surface temperature at the local stimulated area and the knee area on both sides will be recorded.

Procedure: Mild moxibustion with moxa stick

Interventions

To conduct this intervention, we used moxa sticks which were 1.5 cm in diameter, 13 cm long, and weighed 12 gram to perform mild moxibustion manipulation at the control acupoint (the left side Pishu acupoint) or Mingmen acupoint in 2 trial phases. The main ingredient of the moxa was dried mugwort leaf, produced in Vietnam. All moxa materials were obtained from the Sai Gon TCS Co., Ho Chi Minh City, Vietnam.

Group A: P1M2Group B: M1P2

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy males and females were individual age between enough 18 and 30 years old.
  • BMI: 18.5 - 23 kg/m2
  • Mental alertness, good contact, cooperation with researchers.
  • Had no psychiatric stress problem during moxibustion day (confirmed by answering the DASS 21 questionaire with stress point less than 15 points).
  • Had no history of cardio-vascular disease, diabetes, hyperthyroidism, hypothyroidism.
  • Vital sign within normal limits:
  • Heart rates from from 60 to 99 beats/minute.
  • Systolic blood pressure between 90 and 139 mmHg.
  • Diastolic blood pressure between 60 and 89 mmHg.
  • Breathing rate: 16 ± 3 times/minute.
  • Body temperature: 36.59 ± 0.43 ℃.
  • SpO2 from 95 to 100%.
  • Volunteers who agree to participate and sign the Informed Consent Form, following a detailed explanation of clinical trials.
  • Not currently participating in other intervention studies.

You may not qualify if:

  • Having an inflammatory injury in the site of the skin to be investigated.
  • Medical history of asthma or allergy with moxa smoke.
  • Using heat therapy, for example massage, cupping therapy, acupuncture in the site of the skin to be investigated within 24 hours.
  • Applying chemical or pharmaceutical products to the site of the skin to be survey before conducting the study.
  • Other diseases that could affect or interfere with outcomes, including common cold or flu.
  • Playing sport 2 hours before the study.
  • Taking stimulants such as beer, alcohol, coffee and tobacco within 24 hours before conducting the study.
  • Skin surface temperature disorders or sensation disorders at lower-back or knee area.
  • Staying up at night or having insomnia before moxibustion day.
  • Women during menstruation period, pregnancy, or breastfeeding.
  • Currently using certain drugs which dilate blood vessels and drop in blood pressure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Traditional medicine - University of Medicine and Pharmacy of Ho Chi Minh City

Ho Chi Minh City, Vietnam

Location

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: A pilot study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

October 10, 2022

First Posted

October 13, 2022

Study Start

October 1, 2022

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

October 23, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Demographic characteristic and outcome data will be shared

Shared Documents
STUDY PROTOCOL, ICF, CSR

Locations